114 related articles for article (PubMed ID: 12645683)
1. Developing a partnership with NAMI and psychiatric pharmacists.
Roe KK; Dopheide JA; Wincor MZ
Schizophr Bull; 2002; 28(3):525-9. PubMed ID: 12645683
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication.
Phokeo V; Sproule B; Raman-Wilms L
Psychiatr Serv; 2004 Dec; 55(12):1434-6. PubMed ID: 15572574
[TBL] [Abstract][Full Text] [Related]
3. [Practical study for seminar program certified by Japanese Society of Hospital Pharmacists for Clinical Psychiatric Pharmacists organized by Chiba Society of Hospital Pharmacists, and investigation of participants' background and issues for taking board certified psychiatric pharmacy specialists and board certified pharmacists in psychiatric pharmacy certifications using questionnaires].
Tsukiji M; Furuyama H; Hasegawa T; Ishida K; Matsuda K; Fukuda K; Shimizu H
Yakugaku Zasshi; 2010 Sep; 130(9):1197-205. PubMed ID: 20823677
[TBL] [Abstract][Full Text] [Related]
4. Student pharmacist experiences as inpatient psychiatry medication education group leaders during an early immersion program.
McLaughlin JE; Kennedy L; Garris S; Harris SC; Hillman A; Pinelli NR; Rhoney DH
Curr Pharm Teach Learn; 2017 Sep; 9(5):856-861. PubMed ID: 29233315
[TBL] [Abstract][Full Text] [Related]
5. NAMI in our own voice and NAMI smarts for advocacy: self-narrative as advocacy tool.
Pandya A
J Psychiatr Pract; 2012 Nov; 18(6):448-50. PubMed ID: 23160251
[TBL] [Abstract][Full Text] [Related]
6. Pharmacists' views on Indigenous health: is there more that can be done?
Stoneman J; Taylor SJ
Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric pharmacists' perception on the use of pharmacogenomic testing in the mental health population.
Shishko I; Almeida K; Silvia RJ; Tataronis GR
Pharmacogenomics; 2015; 16(9):949-58. PubMed ID: 26100610
[TBL] [Abstract][Full Text] [Related]
8. Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology.
Javelot H; Gitahy Falcao Faria C; Vandenberghe F; Dizet S; Langrée B; Le Maout M; Straczek C; Egron A; Erb A; Sujol G; Yrondi A; Weibel S; Vincent PD; Meyer G; Hingray C
Pharmacy (Basel); 2021 Aug; 9(3):. PubMed ID: 34449724
[TBL] [Abstract][Full Text] [Related]
9. [Some resolutions in difficulties of postgraduate psychiatric education in Japan].
Kojima T; Hosaka T
Seishin Shinkeigaku Zasshi; 2003; 105(2):221-6. PubMed ID: 12708019
[TBL] [Abstract][Full Text] [Related]
10. Role of pharmacists in managing neurologic and psychiatric disorders.
Kachroo S
J Am Pharm Assoc (2003); 2006; 46(3):308. PubMed ID: 17517555
[No Abstract] [Full Text] [Related]
11. Depressed patients' preferences for education about medications by pharmacists in Kuwait.
Al-Saffar N; Abdulkareem A; Abdulhakeem A; Salah AQ; Heba M
Patient Educ Couns; 2008 Jul; 72(1):94-101. PubMed ID: 18337052
[TBL] [Abstract][Full Text] [Related]
12. Family members' ratings of the use and value of mental health services: results of a national NAMI survey.
Hatfield AB; Gearon JS; Coursey RD
Psychiatr Serv; 1996 Aug; 47(8):825-31. PubMed ID: 8837153
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacists as allied health care providers to psychiatric patients.
Gray DR; Namikas EA; Sax MJ; Brinkman J; Cheung A; Gordon M; Parker AG; Welch PH
Contemp Pharm Pract; 1979; 2(3):108-16. PubMed ID: 10242843
[TBL] [Abstract][Full Text] [Related]
14. The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient Outcomes.
Goldstone LW; DiPaula BA; Werremeyer A; Botts S; Hepburn B; Liu HY; Duckworth K; Young AS; Kelly DL
Psychiatr Serv; 2021 Jul; 72(7):794-801. PubMed ID: 33940946
[TBL] [Abstract][Full Text] [Related]
15. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education--2003.
Pedersen CA; Schneider PJ; Scheckelhoff DJ
Am J Health Syst Pharm; 2004 Mar; 61(5):457-71. PubMed ID: 15018223
[TBL] [Abstract][Full Text] [Related]
16. Positioning psychiatric pharmacists to improve mental health care.
Dopheide JA; Werremeyer A; Haight RJ; Gutierrez CA; Williams AM
Ment Health Clin; 2022 Apr; 12(2):77-85. PubMed ID: 35582321
[TBL] [Abstract][Full Text] [Related]
17. [Cooperation between psychiatrists and pharmacists in chemotherapy conducted in psychiatry].
Yoshio T
Seishin Shinkeigaku Zasshi; 2009; 111(10):1256-9. PubMed ID: 20155890
[No Abstract] [Full Text] [Related]
18. Supporting patients with mental illness: Deconstructing barriers to community pharmacist access.
Calogero S; Caley CF
J Am Pharm Assoc (2003); 2017; 57(2):248-255. PubMed ID: 28153705
[TBL] [Abstract][Full Text] [Related]
19. Pharmacy-perceived barriers to cancer pain control: results of the North Carolina Cancer Pain Initiative Pharmacist Survey.
Krick SE; Lindley CM; Bennett M
Ann Pharmacother; 1994; 28(7-8):857-62. PubMed ID: 7949500
[TBL] [Abstract][Full Text] [Related]
20. Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications.
Smith SR; Golin CE; Reif S
Am J Health Syst Pharm; 2004 Jun; 61(11):1120-9. PubMed ID: 15237564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
